Raids put fakes-makers on notice

Last week's multinational effort to crack down on drug counterfeiters--operation Pangea--shows that the public safety threat raises intellectual property theft to a new level. Few stings targeting designer shoes or handbags are likely to have involved Pangea's level of international cooperation and law enforcement effort.

Government officials around the world have taken note of the huge problem, according to the Washington Post. Fake drugs are now the third-largest counterfeiting category, a $28 million market. Last year the represented just 10 percent of total seizures; the year before, 6 percent.

The raids netted 167,000 suspected illicit and counterfeit pills. Worldwide, the operation seized nearly 1,000 packages of suspected counterfeits and dismantled 72 drug web sites. Some 700 of the packages were seized in the U.S.

As we've reported, the growing problem is spawning tracking and thwarting technologies, industry groups, and industry research tracking manufacturer concern.

- read the article

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.